SC
BMY icon

Stance Capital’s Bristol-Myers Squibb BMY Stock Holding History

Stance Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$475K Sell
8,240
-75,957
-90% -$4.36M 0.14% 136
2026
Q1 		$5.11M Buy
84,197
+56,895
+208% +$3.32M 2.48% 3
2025
Q4 		$1.47M Sell
27,302
-7,689
-22% -$370K 0.54% 48
2025
Q3 		$1.58M Buy
34,991
+1,796
+5% +$83.9K 0.58% 41
2025
Q2 		$1.54M Sell
33,195
-9,170
-22% -$450K 0.58% 54
2025
Q1 		$2.58M Buy
42,365
+39,165
+1,224% +$2.28M 1.91% 27
2024
Q4 		$181K Buy
+3,200
New +$179K 0.11% 86

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Stance Capital's BMY Position: Q2 2026 in Review

Stance Capital reduced its Bristol-Myers Squibb (BMY) stake by 90% in Q2 2026, selling an estimated $4.36M and leaving 8,240 shares worth $475K. The position accounts for 0.14% of the portfolio, ranked #136.

Stance Capital first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.11M in Q1 2026. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Stance Capital held 8,240 shares of Bristol-Myers Squibb worth $475K as of Q2 2026.
  • Stance Capital sold 75,957 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.36M.
  • Bristol-Myers Squibb made up 0.14% of Stance Capital's portfolio in Q2 2026, its #136 holding.
  • Stance Capital first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • Stance Capital's Bristol-Myers Squibb position peaked at $5.11M in Q1 2026.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Stance Capital's 13F filing for Q2 2026, filed 14 Aug 2026.